HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage ...

Fintel reports that on November 4, 2025, Keefe, Bruyette & Woods maintained coverage of AXIS Capital Holdings (NYSE:AXS) with ...

Yamaha Motor Corporation, USA, is proud to announce the release its 2026 street motorcycle lineup highlighted by an extensively updated new YZF-R7 Supersport model and the introduction of the all-new ...

A comprehensive review published today in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical ...

Keefe Bruyette lowered the firm’s price target on Axis Capital (AXS) to $119 from $125 and keeps an Outperform rating on the shares. Published ...

CHICAGO - A state appeals panel has agreed an insurance company doesn’t need to contribute to a $28.5 million settlement that ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

At the consolidated level, AXIS recorded underwriting income of US$188 million, up 39% from 2024, and operating income of ...

PEMBROKE, Bermuda (AP) — PEMBROKE, Bermuda (AP) — Axis Capital Holdings Ltd. (AXS) on Wednesday reported third-quarter net income of $301.9 million. On a per-share basis, the Pembroke, Bermuda-based ...